Secretoneurin in the peripheral ocular innervation

Investigative Ophthalmology and Visual Science

Volumn 46, Issue 2, 2005, Pages 647-654

  Troger, Josef ^a,b   Doblinger, Alfred ^a   Leierer, Johannes ^a   Laslop, Andrea ^a   Schmid, Eduard ^a   Teuchner, Barbara ^a   Opatril, Markus ^a   Philipp, Wolfgang ^a   Klimaschewski, Lars ^a   Pfaller, Kristian ^a   Göttinger, Wolfgang ^a   Fischer Colbrie, Reiner ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b Univ Klinik für Allgemeine Psychiatrie und Sozialpsychiatrie   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSAICIN; NEUROPEPTIDE; SECRETONEURIN;

ANGIOGENESIS; ANIMAL TISSUE; ANTERIOR EYE SEGMENT; ARTICLE; CHOROID; CILIARY BODY; CILIARY MUSCLE; CONTROLLED STUDY; CORNEA; EYE; GEL FILTRATION CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; IN SITU HYBRIDIZATION; INNERVATION; NERVE FIBER C; NEUROGENIC INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RAT; SPHINCTER PUPILLAE MUSCLE; SUPERIOR CERVICAL GANGLION; SYMPATHECTOMY; TRABECULAR MESHWORK; TRIGEMINUS GANGLION;

AGED; ANIMALS; ANIMALS, NEWBORN; ANTERIOR EYE SEGMENT; CAPSAICIN; CHROMATOGRAPHY, GEL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; EYE; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; IN SITU HYBRIDIZATION; MALE; NERVE FIBERS; NEUROPEPTIDES; RADIOIMMUNOASSAY; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SECRETOGRANIN II; SUPERIOR CERVICAL GANGLION; SYMPATHECTOMY; TRIGEMINAL GANGLION;

EID: 13944260056     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.04-0425     Document Type: Article

References (72)

1. Kirchmair R, Hogue-Angeletti R, Gutierrez J, Fischer-Colbrie R, Winkler H. Secretoneurin-a neuropeptide generated in brain, adrenal medulla and other endocrine tissues by proteolytic processing of secretogranin II (chromogranin C). Neuroscience. 1993;53: 359-365.
2. Winkler H, Fischer-Colbrie R. The chromogranins A and B: the first 25 years and future perspectives. Neuroscience. 1992;49:497-528.
3. Fischer-Colbrie R, Laslop A, Kirchmair R. Secretogranin II: molecular properties, regulation of biosynthesis and processing to the neuropeptide secretoneurin. Prog Neurobiol. 1995;46:49-70.
4. Marcinkiewicz M, Benjannet S, Seidah NG, Cantin M, Chretien M. Immunocytochemical localization of a novel pituitary protein (7B2) within the rat brain and hypophysis. J Histochem Cytochem. 1985;33:1219-1226.
5. Bauer R, Weiss C, Marksteiner J, Doblinger A, Fischer-Colbrie R, Laslop A. The new chromogranin-like protein NESP55 is preferentially localized in adrenaline-synthesizing cells of the bovine and rat adrenal medulla. Neurosci Lett. 1999;263:13-16.
6. Hagn C, Schmid KW, Fischer-Colbrie R, Winkler H. Chromogranin A, B, and C in human adrenal medulla and endocrine tissues. Lab Invest. 1986;55:405-411.
7. Weiler R, Marksteiner J, Bellmann R, et al. Chromogranins in rat brain: characterization, topographical distribution and regulation of synthesis. Brain Res. 1990;532:87-94.
8. Leitner B, Fischer-Colbrie R, Scherzer G, Winkler H. Secretogranin H: relative amounts and processing to secretoneurin in various rat tissues. J Neurochem. 1996;66:1312-1317.
9. Leitner B, Schneitier C, Klocker H, et al. Formation and sequence analysis of secretoneurin, a neuropeptide derived from secretogranin II, in mammalian, bird, reptile, amphibian and fish brains. Neurosci Lett. 1998;248:105-108.
10. Marksteiner J, Saria A, Kirchmair R, et al. Distribution of secretoneurin-like immunoreactivity in comparison with substance P- and enkephalin-like immunoreactivities in various human forebrain regions. Eur J Neurosci. 1993a;5:1573-1585.
11. Marksteiner J, Saria A, Hinterhuber H. Distribution of secretoneurin-like immunoreactivity in comparison with that of substance P in the human brain stem. J Chem Neuroanatom. 1994a;7:253-270.
12. Kato A, Kammen-Jolly K, Fischer-Colbrie R, Humpel C, Schrott-Fischer A, Marksteiner J. Co-distribution patterns of chromogranin B-like immunoreactivity with chromogranin A and secretoneurin within the human brainstem. Brain Res. 2000;852:444-452.
13. Telser S, Marksteiner J, Hinterhuber H, Saria A. Distribution of secretoneurin-like immunoreactivity in comparison with that of substance P in the human spinal cord. Neurosci Lett. 1995;1991: 83-86.
14. Kaufmann WA, Barnas U, Maier J, Sana A, Alheid GF, Marksteiner J. Neurochemical compartments in the human forebrain: evidence for a high density of secretoneurin-like immunoreactivity in the extended amygdala. Synapse. 1997;26:114-130.
15. Pirker S, Czech T, Baumgartner C, et al. Chromogranins as markers of altered hippocampal circuitry in temporal lobe epilepsy. Ann Neurol. 2001;50:216-226.
16. Marksteiner J, Kirchmair R, Mahata SK, et al. Distribution of secretoneurin, a peptide derived from secretogranin II, in rat brain: an immunocytochemical and radioimmunological study. Neuroscience. 1993b;54:923-944.
17. Marksteiner J, Mahata SK, Pycha R, et al. Distribution of secretoneurin immunoreactivity in the spinal cord and lower brainstem in comparison with that of substance P and calcitonin gene-related peptide. J Comp Neurol. 1994b;340:243-254.
18. Marksteiner J, Lassnig E, Telser S, et al. Evidence for a high density of secretoneurin-like immunoreactivity in the extended amygdala of the rat. J Comp Neurol. 1995;353:275-290.
19. Schwarzer C, Marksteiner J, Kroesen S, Kohl C, Sperk G, Winkler H. Secretoneurin: a marker in rat hippocampal pathways. J Comp Neurol. 1997;377:29-40.
20. Kandlhofer S, Hoertnagl B, Czech T, et al. Chromogranins in temporal lobe epilepsy. Epilepsia. 2000;41(suppl. 6):S111-S114.
21. Troger J, Kirchmair R, Marksteiner J, et al. Release of secretoneurin and noradrenaline from hypothalamic slices and its differential inhibition by calcium channel blockers. Naunyn Schmiedebergs Arch Pharmacol. 1994;349:565-569.
22. Saria A, Troger J, Kirchmair R, Fischer-Colbrie R, Hogue-Angeletti R, Winkler H. Secretoneurin releases dopamine from rat striatal slices: a biological effect of a peptide derived from secretogranin II (chromogranin C). Neuroscience. 1993;54:1-4.
23. Agneter E, Sitte H, Stöckl-Hiesleitner S, Fischer-Colbrie R, Winkler H, Singer EA. Sustained dopamine release induced by secretoneurin in the striatum of the rat: a microdialysis study. J Neurochem. 1995;65:622-625.
24. You ZB, Saria A, Fischer-Colbrie R, Terenius L, Goiny M, Herrera-Marschitz M. Effects of secretogranin II-derived peptides on the release of neurotransmitters monitored in the basal ganglia of the rat with in vivo microdialysis. Naunyn Schmiedebergs Arch Pharmacol. 1996;354:717-724.
25. Reinisch N, Kirchmair R, Kahler CM, et al. Attraction of human monocytes by the neuropeptide secretoneurin. FEBS Lett. 1993; 334:41-44.
26. Schratzberger P, Reinisch N, Kahler CM, Wiedermann CJ. Deactivation of chemotaxis of human neutrophils by priming with secretogranin II-derived secretoneurin. Reg Peptides. 1996;63:65-71.
27. Schratzberger P, Woll E, Reinisch N, Kahler CM, Wiedermann CJ. Secretoneurin-induced in vitro chemotaxis of human monocytes is inhibited by pertussis toxin and an inhibitor of protein kinase C. Neurosci Lett. 1996;214:208-210.
28. Schratzberger P, Reinisch N, Prodinger WM, et al. Differential chemotactic activities of sensory neuropeptides for human peripheral blood mononuclear cells. J Immunol. 1997;158:3895-3901.
29. Dunzendorfer S, Schratzberger P, Reinisch N, Kahler CM, Wiedermann CJ. Secretoneurin, a novel neuropeptide, is a potent chemoattractant for human eosinophils. Blood. 1998;91:1527-1532.
30. Kirchmair R, Gander R, Egger M, et al. The neuropeptide secretoneurin acts as a direct angiogenic cytokine in vitro and in vivo. Circulation. 2004;109:777-783.
31. 125I-secretoneurin analogue to a human monocytic cell line. J Neuroimmunol. 1998;86:87-91.
32. Kong C, Gill BM, Rahimpour R, et al. Secretoneurin and chemoattractant receptor interactions. J Neuroimmunol. 1998;88:91-98.
33. Schmid KW, Kunk B, Kirchmair R, Tötsch M, Bocker W, Fischer-Colbrie R. Immunohistochemical detection of secretoneurin, a novel neuropeptide endoproteolytically processed from secretogranin II, in normal human endocrine and neuronal tissues. Histochem J. 1995;27:473-481.
34. Klimaschewski L, Benndorf K, Kirchmair R, Fischer-Colbrie R, Heym C. Secretoneurin-immunoreactivity in nerve terminals apposing identified preganglionic sympathetic neurons in the rat: colocalization with substance P and enkephalin. J Chem Neuroanatom. 1995;9:55-63.
35. Klimaschewski L, Kroesen S, Eder U, Leitner B, Fischer-Colbrie R. Localization and axotomy-induced regulation of the peptide secretoneurin in the rat superior cervical ganglion. Eur J Neurosci. 1996;8:1953-1964.
36. Schurmann G, Bishop AE, Facer P, et al. Secretoneurin: a new peptide in the human enteric nervous system. Histochem Cell Biol. 1995;104:11-19.
37. Dun NJ, Dun SL, Lin HH, Hwang LL, Saria A, Fischer-Colbrie R. Secretoneurin-like immunoreactivity in rat sympathetic, enteric and sensory ganglia. Brain Res. 1997;760:8-16.
38. Li JY, Leitner B, Winkler H, Dahlstrom A. Distribution of chromogranins A and B and secretogranin II (secretoneurin) in rat pelvic neurons and vas deferens. Neuroscience. 1998;84:281-294.
39. Collins JJ, Wilson K, Fischer-Colbrie R, Papka RE. Distribution and origin of secretoneurin-immunoreactive nerves in the female rat uterus. Neuroscience. 2000;95:255-264.
40. Overdick B, Kirchmair R, Marksteiner J, et al. Presence and distribution of a new neuropeptide, secretoneurin, in human retina. Peptides. 1996;17:1-4.
41. Kralinger MT, Hinterhölzl J, Troger J, et al. Elevated levels of secretoneurin in the rabbit aqueous humor in response to formaldehyde irritation. Graefes Arch Clin Exp Ophthalmol. 2003;241: 577-581.
42. Unger WG. Mediation of the ocular response to injury and irritation: peptides versus prostaglandins. Prog Clin Biol Res. 1989;312:293-328.
43. Kirchmair R, Marksteiner J, Troger J, et al. Human and rat primary C-fiber afferents store and release secretoneurin, a novel neuropeptide. Eur J Neurosci. 1994;6:861-868.
44. Holzer P. Local effector functions of capsaicin-sensitive sensory nerve endings: involvement of tachykinins, calcitonin gene-related peptide and other neuropeptides. Neuroscience. 1988;24:739-768.
45. Holzer P. Capsaicin as a tool to study sensory neuron functions. Adv Exp Med Biol. 1991;298:3-16.
46. Holzer P. Capsaicin: cellular targets, mechanisms of action, and selectivity for thin sensory neurons. Pharmacol Rev. 1991;43: 143-201.
47. Mahata M, Mahata SK, Fischer-Colbrie R, Winkler H. Ontogenetic development and distribution of mRNAs of chromogranin A and B, secretogranin II, p65 and synaptin/synaptophysin in rat brain. Dev Brain Res. 1993;76:43-58.
48. Wang ZY, Alm P, Hakanson R. Distribution and effects of pituitary adenylate cyclase-activating peptide in the rabbit eye. Neuroscience. 1995;69:297-308.
49. Lazarov NE. Comparative analysis of the chemical neuroanatomy of the mammalian trigeminal ganglion and mesencephalic trigeminal nucleus. Prog Neurobiol. 2002;66:19-59.
50. Ogilvy CS, Silverberg KR, Borges LF. Sprouting of corneal sensory fibers in rats treated at birth with capsaicin. Invest Ophthalmol Vis Sci. 1991;32:112-121.
51. Allen JM, McGregor GP, Adrian TE, et al. Reduction of neuropeptide Y (NPY) in the rabbit iris-ciliary body after chronic sympathectomy. Exp Eye Res. 1983;37:213-215.
52. Terenghi G, Polak JM, Allen JM, Zhang SQ, Unger WG, Bloom SR. Neuropeptide Y-immunoreactive nerves in the uvea of guinea pig and rat. Neurosci Lett. 1983;42:33-38.
53. Zhang SQ, Terenghi G, Unger WG, Ennis KW, Polak J. Changes in substance P- and neuropeptide Y-immunoreactive fibres in rat and guinea pig indes following unilateral sympathectomy. Exp Eye Res. 1984;39:365-372.
54. Stone RA, Kuwayama Y, Laties AM. Regulatory peptides in the eye. Experientia. 1987;43:791-800.
55. Stone RA, Kuwayama Y. Substance P-like immunoreactive nerves in the human eye. Arch Ophthalmol. 1985;103:1207-1211.
56. Stone RA, McGlinn AM. Calcitonin gene-related peptide immunoreactive nerves in human and rhesus monkey eyes. Invest Ophthalmol Vis Sci. 1988;29:305-310.
57. Jones MA, Marfurt CF. Peptidergic innervation of the rat cornea. Exp Eye Res. 1998;66:421-435.
58. Stone RA, Tervo T, Tervo K, Tarkkanen A. Vasoactive intestinal polypeptide-like immunoreactive nerves to the human eye. Acta Ophthalmol (Copenh). 1986;64:12-18.
59. Stone RA. Neuropeptide Y and the innervation of the human eye. Exp Eye Res. 1986;42:349-355.
60. Ortego J, Escribano J, Crabb J, Coca-Prados M. Identification of a neuropeptide and neuropeptide-processing enzymes in aqueous humor confers neuroendocrine features to the human ocular ciliary epithelium. J Neurochem. 1996;66:787-796.
61. Coca-Prados M, Escribano J, Ortego J. Differential gene expression in the human ciliary epithelium. Prog Retin Eye Res. 1999;18:403-429.
62. Wang ZY, Alm P, Hakanson R. PACAP occurs in sensory nerve fibers and participates in ocular inflammation in the rabbit. Ann N Y Acad Sci. 1996;805:779-783.
63. Wang ZY, Waldeck K, Grundemar L, Hakanson R. Ocular inflammation induced by electroconvulsive treatment: contribution of nitric oxide and neuropeptides mobilized from C-fibers. Br J Pharmacol. 1997;120:1491-1496.
64. Wang ZY, Alm P, Hakanson R. The contribution of nitric oxide to endotoxin-induced ocular inflammation: interaction with sensory nerve fibres. Br J Pharmacol. 1996;118:1537-1543.
65. Kähler CM, Fischer-Colbrie R. Secretoneurin: a novel link between the nervous and the immune system-conservation of the sequence and functional aspects. Adv Exp Med Biol. 2000;482:279-290.
66. Kähler CM, Bellmann R, Reinisch N, Schratzberger P, Gruber B, Wiedermann CJ. Stimulation of human skin fibroblast migration by the neuropeptide secretoneurin. Eur J Pharmacol. 1996;304:135-139.
67. Kähler CM, Kirchmair R, Kaufmann G, et al. Inhibition of proliferation and stimulation of migration of endothelial cells by secretoneurin in vitro. Arterioscler Thromb Vasc Biol. 1997;17:932-939.
68. Kähler CM, Schratzberger P, Wiedermann CJ. Response of vascular smooth muscle cells to the neuropeptide secretoneurin: a functional role for migration and proliferation in vitro. Arterioscler Thromb Vasc Biol. 1997;17:2029-2035.
69. Sharp PS. The role of growth factors in the development of diabetic retinopathy. Metabolism. 1995;44(suppl 4):72-75.
70. Marti E, Ferrer I, Blasi J. Differential regulation of chromogranin A, chromogranin B and secretoneurin protein expression after transient forebrain ischemia in the gerbil. Acta Neuropathol (Berl). 2001;101:159-166.
71. Ziehe M, Morbidelli L, Pacini M, Geppetti P, Alessandri G, Maggi CA. Substance P stimulates neovascularization in vivo and proliferation of cultured endothelial cells. Microvasc Res. 1990;40:264-278.
72. Zukowska-Grojec Z, Karwatowska-Prokopczuk E, Rose W, et al. Neuropeptide Y: a novel angiogenic factor from the sympathetic nerves and endothelium. Circ Res. 1998;83:187-195.